Book MEN Genetic Screening in Saudi Arabia | Lahalak Medical Platform

Advanced genetic screening to detect mutations causing Multiple Endocrine Neoplasia syndromes. This test enables early detection and proactive prevention strategies for individuals and families at higher hereditary cancer risk.

Scientific name: Multiple Endocrine Neoplasia (MEN) Genetic Screening

A specialized laboratory test screening for RET, MEN1, and CDKN1B gene mutations. It identifies risks for Multiple Endocrine Neoplasia syndromes types 1 and 2, facilitating early medical intervention.

Multiple Endocrine Neoplasia (MEN) Genetic Screening - Screen Your Family's Endocrine Health
Service type Genetic Test
Duration 10-15 minutes
Fasting Fasting is not required

Included Services

  • Blood sample collection
  • DNA analysis
  • Genetic results report

Medical Service Information

Importance of Genetic Screening

  • Identifying hereditary predisposition to endocrine tumors.
  • Enabling early surgical or medical intervention before symptoms appear.
  • Assisting family members in understanding mutation inheritance risks.

Targeted Genes

  • MEN1 gene: Associated with MEN type 1 syndrome.
  • RET gene: Associated with MEN type 2 and medullary thyroid carcinoma.
  • CDKN1B gene: Associated with MEN type 4 syndrome.

Who Should Consider This Test?

  • Individuals diagnosed with multiple endocrine tumors (pituitary, thyroid, adrenal).
  • Having a first-degree relative diagnosed with MEN syndrome.
  • Personal history of medullary thyroid cancer at a young age.

Conditions & Notices

  • Preferable to provide previous medical reports if there is a family history

Medical services you might also like